Previous Close | 6.25 |
1-Year Change | 20.89% |
6-Months Change | -16.44% |
3-Months Change | -33.08% |
Moving Avg (50d) | 7.0904 |
Moving Avg (200d) | 7.7226 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 444.3M |
Beta (3-Years) | 1.05 |
Revenue Growth (ttm) | -83.8% |
Net Profit Margin (ttm) | -14.37% |
Return On Assets (ttm) | -3.16% |
EPS (ttm) | -0.07 |
PE Ratio (ttm) | -89.29 |
Dividend Yield | 14.4% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |